Publicaciones en las que colabora con ESTEBAN JESUS MORCILLO SANCHEZ (17)

2013

  1. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-ii

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 1, pp. 96-104

  2. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium

    Thorax, Vol. 68, Núm. 2, pp. 177-186

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2009

  1. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan

    Journal of Immunology, Vol. 183, Núm. 2, pp. 1393-1402

  2. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury

    British Journal of Pharmacology, Vol. 156, Núm. 3, pp. 534-544

2007

  1. A critical role for TNFα in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles

    Blood, Vol. 110, Núm. 6, pp. 1895-1902

  2. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 11, pp. 2370-2376

  3. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability

    British Journal of Pharmacology, Vol. 152, Núm. 4, pp. 481-492

2006

  1. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines

    Journal of Immunology, Vol. 176, Núm. 9, pp. 5577-5586

2005

  1. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neurtrophil recruitment in vivo

    Journal of Leukocyte Biology, Vol. 78, Núm. 3, pp. 696-704

  2. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression

    British Journal of Pharmacology, Vol. 144, Núm. 2, pp. 190-201

  3. Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells

    Thorax, Vol. 60, Núm. 2, pp. 144-152

2004

  1. Erratum: Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo (British Journal of Pharmacology (2003) 140 (1057-1067) DOI: 10.1038/sj.bjp.0705525))

    British Journal of Pharmacology

2003

  1. Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo

    British Journal of Pharmacology, Vol. 140, Núm. 6, pp. 1057-1067

  2. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats

    European Respiratory Journal, Vol. 22, Núm. 6, pp. 900-905

2002

  1. Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation

    British Journal of Pharmacology, Vol. 135, Núm. 8, pp. 1872-1881

2001

  1. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats

    European Respiratory Journal, Vol. 17, Núm. 6, pp. 1228-1235